NCT07535320 Study of Patient Preferences in Dialysis Treatment Choice: a Discrete Choice Experiment
| NCT ID | NCT07535320 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Caen |
| Condition | End Stage Chronic Renal Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-12-16 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2025-12-16 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background Compared to in-center dialysis, home dialysis is associated with better quality of life and lower healthcare system costs. However, barriers remain to its wider adoption. Chronic disease, particularly at an advanced stage, is a major driver of socioeconomic vulnerability. Among dialysis patients, the proportion of individuals covered by France's Universal Health Protection scheme (PUMA) is higher than in the general population. Similarly, those from the most disadvantaged social classes are overrepresented among dialysis patients compared to the overall French population. Dialysis can also lead to job loss. Financial compensation schemes may influence the choice of home dialysis. In France, patients who perform dialysis at home-either independently or with help from a trained family caregiver-are eligible for a "third-person compensatory allowance" (DTP). For some socioeconomically vulnerable patients, eligibility for DTP may influence their decision to opt for home treatment. The DTP is specific to the French healthcare system but could be considered in other countries, particularly within the European Union. Indeed, in most countries with income levels comparable to France, the additional cost of home dialysis is borne by the patient. This study aims to determine whether receiving financial compensation plays a role in choosing a dialysis modality (home-based versus in-center or assisted home dialysis). Objectives To investigate factors associated with patient preferences regarding renal replacement therapy. Methods A discrete choice experiment (DCE) was conducted comparing two options: home dialysis (PD and HHD, with DTP) versus in-center hemodialysis (no DTP). Perspectives If financial compensation influences patients' choices toward home dialysis, the DTP model could be used to address barriers to home-based treatment.
Eligibility Criteria
Inclusion Criteria: * Adult patient * Patient with advanced chronic kidney disease receiving pre-surgery information (presentation of methods) * Patient enrolled in a social security program * Patient able to read and understand French * Patient able to complete the questionnaire (cognitive and sensory) Exclusion Criteria: * Minor patients * Patients transitioning from one method of extrarenal purification to another * Patients requiring urgent dialysis * Patients who cannot read or understand French * Patients under legal protection (guardianship, curatorship, judicial protection)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07535320 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying End Stage Chronic Renal Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07535320 currently recruiting?
Yes, NCT07535320 is actively recruiting participants. Contact the research team at tomadesso-c@chu-caen.fr for enrollment information.
Where is the NCT07535320 trial being conducted?
This trial is being conducted at Caen, France, Caen, France.
Who is sponsoring the NCT07535320 clinical trial?
NCT07535320 is sponsored by University Hospital, Caen. The trial plans to enroll 500 participants.